Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer

ClinicalTrials.gov ID: NCT00657904

Public ClinicalTrials.gov record NCT00657904. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double-Blind Comparative Trial of Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to study the effect - in terms of time to progression and overall survival - of 2 years of adjuvant bicalutamide 150mg monotherapy, versus placebo, in subjects with histologically or cytologically confirmed non-metastatic adenocarcinoma of the prostate gland.

Study identification

NCT ID
NCT00657904
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
3,618 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 1995 (Type not available)
Primary completion
Jul 2008 (Actual)
Completion
Aug 2008 (Actual)
Last update posted
Jun 6, 2012

1995 – 2008

United States locations

U.S. sites
72
U.S. states
34
U.S. cities
72
Facility City State ZIP Site status
Research Site Birmingham Alabama — —
Research Site Mobile Alabama — —
Research Site Scottsdale Arizona — —
Research Site Tucson Arizona — —
Research Site Berkeley California — —
Research Site Laguna Woods California — —
Research Site Newport Beach California — —
Research Site San Diego California — —
Research Site San Francisco California — —
Research Site Santa Monica California — —
Research Site Thousand Oaks California — —
Research Site Torrance California — —
Research Site Van Nuys California — —
Research Site Denver Colorado — —
Research Site Middlebury Connecticut — —
Research Site New Haven Connecticut — —
Research Site Washington D.C. District of Columbia — —
Research Site Aventura Florida — —
Research Site Bay Pines Florida — —
Research Site Boca Raton Florida — —
Research Site Daytona Beach Florida — —
Research Site Fort Myers Florida — —
Research Site Gainesville Florida — —
Research Site Miami Florida — —
Research Site Ocala Florida — —
Research Site Saint Augustine Florida — —
Research Site Atlanta Georgia — —
Research Site Chicago Illinois — —
Research Site Fort Wayne Indiana — —
Research Site Greenwood Indiana — —
Research Site Iowa City Iowa — —
Research Site Kansas City Kansas — —
Research Site Louisville Kentucky — —
Research Site Shreveport Louisiana — —
Research Site Greenbelt Maryland — —
Research Site Rockville Maryland — —
Research Site Burlington Massachusetts — —
Research Site Newtown Massachusetts — —
Research Site Ann Arbor Michigan — —
Research Site Detroit Michigan — —
Research Site Rochester Minnesota — —
Research Site Hattiesburg Mississippi — —
Research Site Jackson Mississippi — —
Research Site St Louis Missouri — —
Research Site Omaha Nebraska — —
Research Site Lebanon New Hampshire — —
Research Site Albany New York — —
Research Site Manhasset New York — —
Research Site New York New York — —
Research Site Rochester New York — —
Research Site Syracuse New York — —
Research Site The Bronx New York — —
Research Site Asheville North Carolina — —
Research Site Durham North Carolina — —
Research Site Raleigh North Carolina — —
Research Site Cincinnati Ohio — —
Research Site Portland Oregon — —
Research Site Lancaster Pennsylvania — —
Research Site Philadelphia Pennsylvania — —
Research Site Cordova Tennessee — —
Research Site Nashville Tennessee — —
Research Site Dallas Texas — —
Research Site Houston Texas — —
Research Site San Antonio Texas — —
Research Site Salt Lake City Utah — —
Research Site Danville Virginia — —
Research Site Richmond Virginia — —
Research Site Virginia Beach Virginia — —
Research Site Seattle Washington — —
Research Site Madison Wisconsin — —
Research Site Milwaukee Wisconsin — —
Research Site Cheyenne Wyoming — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00657904, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 6, 2012 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00657904 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →